Psoriatic arthritis

Nigil Haroon MD, PhD, DM, FRCPC, FRCP, MBA NigilHaroon
1 year 7 months ago
The dynamic Dr. Vinod Chandran, talking about metabolomics in #psoriaticDisease
#ACR23
The metabolomics facility was established recently at the @UHN @UofT @SchroederInst and we are already seeing the results. @KrembilF @CRASCRRheum @UofTRheum https://t.co/Azxq3k8w5g


Robert B Chao, MD
1 year 7 months ago
Large French study on infection risk of PsA biologics
12k pts over 6 years
When compared to Humira, only Enbrel and Stelara had lower infection risk
Concurrent steroid use associated with increased infection 1.85HR
@RheumNow #ACR23 Abs#2566 https://t.co/Os1esuodfl


Richard Conway
1 year 7 months ago
Bastard et al. 12,071 French PsA. Low incidence serious infections on advanced therapy - 17 per 1,000 person-years. Significantly lower risk ETN (HR 0.70), UST (HR 0.56) vs ADA. Others similar. Abstr#2566 #ACR23 @RheumNow https://t.co/GGDvRxP9ht https://t.co/Ol7G1OG73t


Dr. John Cush RheumNow
1 year 7 months ago
Do Probiotics Improve PsA?
Probiotics and gut microbiome is a hot topic in the research world and amongst patients. Often, one the questions I get after sharing the diagnosis of PsA is, “Is there anything I can eat/not eat to make this better?” #ACR23
https://t.co/aK56UXz3gs https://t.co/p2AuzcWyq9


sheila
1 year 7 months ago
In this Ph2b RCT of TAK-279 (TYK2i), pts w/ PsA given 15mg & 30mg achieved an ACR20 response at wk 12 vs. PBO(53.3% and 54.2% vs 29.2%, both p = 0.002)
⬆️common TEAEs: Npharyngitis, URTI, headache & rash
#ACR23 ABSL12 @RheumNow https://t.co/T6swJgw6vE


Mithu Maheswaranathan, MD
1 year 7 months ago
Part 2: Clinical Year in Review #ACR23 https://t.co/Yb8Xh2UKFY


Dr. John Cush RheumNow
1 year 7 months ago
Daily Recap - TUESDAY https://t.co/Vq5BSHmPsv

Robert B Chao, MD
1 year 7 months ago
Does clinical enthesitis correlate with ultrasound enthesitis in psoriatic pts?
52 wk study randomized to secukinumab or placebo found a long-term stable response of enthesitis control
BUT NO correlation between clinical & US enthesitis
@RheumNow #ACR23 Abs#2243 https://t.co/H7pESzYrNi


Robert B Chao, MD
1 year 7 months ago
Persistence of IL-17i vs. TNFi in PsA treatment
Large database study
Persistence of IL-17i slightly greater than TNFi over 12 months
Are IL-17i a better longterm strategy for PsA pts?
@RheumNow #ACR23 Abs# 2240 https://t.co/9km5XgXcLE


Janet Pope
1 year 7 months ago
Who uses #cannabis in #rheumatic #diseases? Those who smoke, have higher pain, more anxiety, poor sleep are more likely to have used cannabis for their rheumatic disease. Half of the >2900 respondents have tried #cannabis. Use of #biologics reduced use. #980 @RheumNow @ACRheum https://t.co/DQDRQN40zR


RWCS RWCSmtg
1 year 7 months ago
Comorbidities, including heightened CV risk, are linked to severe psoriasis. However, understanding subclinical CV disease timing in psoriasis patients remains limited. Dr. Jack Cush at .@RheumNow explains why more research is needed in this area: https://t.co/3KqQavVEbP https://t.co/Xo8SH0RTh9
